Position in ZTS
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$1,723,777
-$10,915,236 QoQ
Shares Held
23,988
-77.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#512
of 1,408 holders
Holding Since
Jun 2021
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DEARBORN PARTNERS LLC holds $1,723,777 across 1 Drug Manufacturers - Specialty & Generic name. ZTS ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
23,988 | $1,723,777 |
All Filings in ZTS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,723,777 | 23,988 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $12,639,013 | 106,920 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $14,113,732 | 112,174 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $18,023,112 | 123,176 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $19,905,925 | 127,643 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $20,298,875 | 123,285 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $24,167,895 | 148,333 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $29,645,007 | 151,730 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $26,953,666 | 155,478 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $26,263,591 | 155,213 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $244,146 | 1,237 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $200,772 | 1,154 | Shares | Sole | 2023-11-01 | |
| 2021-12-31 | $241,833 | 991 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $238,598 | 1,229 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $221,768 | 1,190 | Shares | Sole | 2021-07-26 | |
| No filing history on record for this holder in this stock. | ||||||